General Head and Neck Cancer News

CancerConnect head and neck cancer news, tips, and features provide breaking research stories, helpful tips, and inspiring features related to ovarian cancer. The unique daily cancer news service evaluates all aspects of head and neck cancer research and reports on the developments that are most important to cancer patients and healthcare providers, while the tips and features offer insight into all aspects of head and neck cancer treatment and survivorship.


Recent General Head and Neck Cancer News

Announcing the CancerConnect Head and Neck Cancer Support Community (September 14, 2016)

Your story matters. Head and neck cancer is a challenging diagnosis, connecting with others who have had to deal with the side effects of treatment and the challenges of treatment decision making is an... Continue Reading

Have a Question about Head and Neck Cancer? Ask the Expert! (September 12, 2016)

CancerConnect and The Ohio State University Comprehensive Cancer Center- James Cancer Hospital and Solove Research Institute Will Present: Ask the Expert with Dr. Kang CancerConnect in collaboration with... Continue Reading

Head and Neck Cancer Immunotherapy Study with AXAL Advances to Second Stage (August 29, 2016)

Advaxis, Inc. (ADXS), a clinical-stage biotechnology company developing cancer immunotherapies, today announced that its Phase 2 “window of opportunity” clinical study of its lead immunotherapy candidate,... Continue Reading

Keytruda® Approved for Advanced Head and Neck Cancer (August 24, 2016)

The United States Food and Drug Administration (FDA) has approved Keytruda® (pembrolizumab) for the treatment of advanced head and neck cancer that has stopped responding to platinum-based chemotherapy... Continue Reading

Compliance with Radiation Schedules Improves Survival in Head and Neck Cancer (June 9, 2016)

Patients with head and neck cancer who comply with their scheduled radiation treatments have significantly improved outcomes compared to those who miss 2 or more of their appointments within the prescribed... Continue Reading

Long-Lasting Responses Achieved with Keytruda® in Advanced Head and Neck Cancer (June 8, 2016)

Treatment with the immune-stimulating agent, Keytruda® (pembrolizumab), provides impressive long-term outcomes for some patients with metastatic or recurrent head and neck cancer. These results were recently... Continue Reading

Follow-Up Scans Reduce Need for Some Invasive Surgeries in Head and Neck Cancer (June 6, 2016)

Utilizing PET-CT scans following treatment for patients with head and neck cancer that has spread to their lymph nodes significantly reduces the need for invasive follow-up surgery. These results were... Continue Reading

More Evidence that PD-1 Inhibitors Improve Survival in Head and Neck Cancer (May 25, 2016)

Results from a recent large trial indicate that treatment with the immunotherapy agent Opdivo® (nivolumab) nearly doubles the survival rate at one year in patients with advanced head and neck squamous... Continue Reading

Addition of Chemotherapy Improves Survival in Some Elderly Patients with Head and Neck Cancer (May 12, 2016)

The addition of chemotherapy to radiation therapy (chemoradiation) improves survival among a subset of elderly patients with advanced head and neck cancer.  These results were recently presented at the... Continue Reading

Getting Your Head Around the Human Papillomavirus (May 1, 2016)

You may have heard about HPV’s role in cervical cancer, but what about head and neck cancer? By Kari Bohlke, ScD The human papillomavirus (HPV) has been in the news a great deal lately, but how much... Continue Reading

Next Page »

Sign up for the CancerConnect newsletter

Sign up for our newsletter and receive the latest news and updates about specific types of cancer.

  Close |  Please don't show me this again

Facebook Twitter RSS